Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 May;48(2):458–468.

The assessment of anti-idiopathic antibodies as effective immunoregulatory probes in vivo.

J C Olson, C R Wagner, G A Leslie
PMCID: PMC1536463  PMID: 7049456

Abstract

In order to increase our understanding of the potential to use anti-idiotypic antibodies as immune modulators in vivo, we extensively analysed influences induced by one such antibody (anti-Id-l) following its administration to animals of different ages, genetic backgrounds, and immunological histories. Id-l is an inter-strain idiotype associated with rat anti-Group A streptococcal carbohydrate antibodies. The intraperitoneal (i.p.) injection of anti-Id-l antibodies, prepared against Id-l+ antibodies from an HPR rat could effectively induce long-term idiotype suppression in all tested strains of rats, regardless of the age at the time of treatment, the RTl haplotype or IgG2c or k-chain allotype. Total anti-streptococcal antibodies were not suppressed by this treatment. Although long-term suppression could be induced at any age, the percentage of animals suppressed following neonatal injections was consistently less than that following adult injections of anti-idiotypic antibodies. In addition, neonatal injections of anti-Id-l or Id-l with anti-Id-l appeared to enhance Id-l production in a minority of the animals. Similar treatment of adult animals never increased Id-l synthesis, suggesting that cells associated with enhanced Id-l production in older animals are either refractory to activation-differentiation signals and/or are sequestered and no longer accessible by i.v. or i.p. routes of administration of the probe. Auto-anti-Id-l immunity induced by immunizing adult rats with heavy, light, F(ab')2 fragments or whole IgG molecules could also induce an Id-l suppressed state. We were not able to induce significant Id-l suppression if animals were immunized with antigen prior to the injection of anti-Id-l. There was evidence, however, that such treatment might lead in time to the development of some idiotype specific suppression.

Full text

PDF
458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbas A. K., Klaus G. G. Inhibition of antibody production in plasmacytoma cells by antigen. Eur J Immunol. 1977 Oct;7(10):667–674. doi: 10.1002/eji.1830071003. [DOI] [PubMed] [Google Scholar]
  2. Beatty P. G., Kim B. S., Rowley D. A., Coppleson L. W. Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor. J Immunol. 1976 May;116(5):1391–1396. [PubMed] [Google Scholar]
  3. Bellgrau D., Wilson D. B. Immunological studies of T-cell receptors. II. Limited polymorphism of idiotypic determinants on T-cell receptors specific for major histocompatibility complex alloantigens. J Exp Med. 1979 Jan 1;149(1):234–243. doi: 10.1084/jem.149.1.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Binz H., Wigzell H. Successful induction of specific tolerance to transplantation antigens using autoimmunisation against the recipient's own natural antibodies. Nature. 1976 Jul 22;262(5566):294–295. doi: 10.1038/262294a0. [DOI] [PubMed] [Google Scholar]
  5. Bona C., Stein K. E., Lieberman R., Paul W. E. Direct and indirect suppression induced by anti-idiotype antibody in the inulin-bacterial levan antigenic system. Mol Immunol. 1979 Dec;16(12):1093–1101. doi: 10.1016/0161-5890(79)90043-9. [DOI] [PubMed] [Google Scholar]
  6. Bottomly K., Mathieson B. J., Mosier D. E. Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice. J Exp Med. 1978 Nov 1;148(5):1216–1227. doi: 10.1084/jem.148.5.1216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bridges S. H. Participation of the humoral immune system in the myeloma-specific transplantation resistance. J Immunol. 1978 Aug;121(2):479–483. [PubMed] [Google Scholar]
  8. Brown C. A., Carey K., Colvin R. B. Inhibition of autoimmune tubulointerstitial nephritis in guinea pigs by heterologous antisera containing anti-idiotype antibodies. J Immunol. 1979 Nov;123(5):2102–2107. [PubMed] [Google Scholar]
  9. Brown S., Dilley J., Levy R. Immunoglobulin secretion by mouse X human hybridomas: an approach for the production of anti-idiotype reagents useful in monitoring patients with B cell lymphoma. J Immunol. 1980 Sep;125(3):1037–1043. [PubMed] [Google Scholar]
  10. Cosenza H., Julius M. H., Augustin A. A. Idiotypes as variable region markers: analogies between receptors on phosphorylcholine-specific T and B lymphocytes. Immunol Rev. 1977;34:3–33. doi: 10.1111/j.1600-065x.1977.tb00366.x. [DOI] [PubMed] [Google Scholar]
  11. Dohi Y., Nisonoff A. Suppression of idiotype and generation of suppressor T cells with idiotype-conjugated thymocytes. J Exp Med. 1979 Oct 1;150(4):909–918. doi: 10.1084/jem.150.4.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eichmann K. Idiotype suppression. I. Influence of the dose and of the effector functions of anti-idiotypic antibody on the production of an idiotype. Eur J Immunol. 1974 Apr;4(4):296–302. doi: 10.1002/eji.1830040413. [DOI] [PubMed] [Google Scholar]
  13. Eichmann K., Rajewsky K. Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol. 1975 Oct;5(10):661–666. doi: 10.1002/eji.1830051002. [DOI] [PubMed] [Google Scholar]
  14. Førre O., Dobloug J. H., Michaelsen T. E., Natvig J. B. Evidence of similar idiotypic determinants on different rheumatoid factor populations. Scand J Immunol. 1979 Mar;9(3):281–289. doi: 10.1111/j.1365-3083.1979.tb02732.x. [DOI] [PubMed] [Google Scholar]
  15. Hart D. A., Wang A. L., Pawlak L. L., Nisonoff A. Suppression of idiotypic specificities in adult mice by administration of antiidiotypic antibody. J Exp Med. 1972 Jun 1;135(6):1293–1300. doi: 10.1084/jem.135.6.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hetzelberger D., Eichmann K. Idiotype suppression. III. Induction of unresponsiveness to sensitization with anti-idiotypic antibody: identification of the cell types tolerized in high zone and in low zone, suppressor cell-mediated, idiotype suppression. Eur J Immunol. 1978 Dec;8(12):839–846. doi: 10.1002/eji.1830081204. [DOI] [PubMed] [Google Scholar]
  17. Hough D. W., Eady R. P., Hamblin T. J., Stevenson F. K., Stevenson G. T. Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes. J Exp Med. 1976 Oct 1;144(4):960–969. doi: 10.1084/jem.144.4.960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Janeway C. A., Jr, Sakato N., Eisen H. N. Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2357–2360. doi: 10.1073/pnas.72.6.2357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kunkel H. G., Agnello V., Joslin F. G., Winchester R. J., Capra J. D. Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity. J Exp Med. 1973 Feb 1;137(2):331–342. doi: 10.1084/jem.137.2.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lanier L. L., Babcock G. F., Raybourne R. B., Arnold L. W., Warner N. L., Haughton G. Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum. J Immunol. 1980 Oct;125(4):1730–1736. [PubMed] [Google Scholar]
  21. Leslie G. A. Expression of a cross reactive idiotype on the IgG2c subclass of rat anti-streptococcal carbohydrate antibody. Mol Immunol. 1979 Apr;16(4):281–285. doi: 10.1016/0161-5890(79)90067-1. [DOI] [PubMed] [Google Scholar]
  22. Leslie G. A., Hattier P. Detection and quantitation of chicken antibodies to streptococcal carbohydrate by high-salt reverse radial immunodiffusion. J Immunol Methods. 1974 Jan;3(1):53–58. doi: 10.1016/0022-1759(74)90033-7. [DOI] [PubMed] [Google Scholar]
  23. Nagelkerken L. M., Aalberse R. C., van Walbeek H. K., Out T. A. Preparation of antisera directed against the idiotype(s) of immunoglobulin G from the cerebrospinal fluid of patients with multiple sclerosis. J Immunol. 1980 Jul;125(1):384–389. [PubMed] [Google Scholar]
  24. Nisonoff A., Ju S. T., Owen F. L. Studies of structure and immunosuppression of cross-reactive idiotype in strain A mice. Immunol Rev. 1977;34:89–118. doi: 10.1111/j.1600-065x.1977.tb00369.x. [DOI] [PubMed] [Google Scholar]
  25. Olson J. C., Leslie G. A. Inheritance patterns of idiotype expression: maternal-fetal immune regulatory networks. Immunogenetics. 1981;13(1-2):39–56. doi: 10.1007/BF00524604. [DOI] [PubMed] [Google Scholar]
  26. Owen F. L., Nisonoff A. Effect of idiotype-specific suppressor T cells on primary and secondary responses. J Exp Med. 1978 Jul 1;148(1):182–194. doi: 10.1084/jem.148.1.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pawlak L. L., Hart D. A., Nisonoff A. Suppression of immunological memory for a cross-reactive idiotype in adult mice. Eur J Immunol. 1974 Jan;4(1):10–13. doi: 10.1002/eji.1830040104. [DOI] [PubMed] [Google Scholar]
  28. Sakato N., Hall S. H., Eisen H. N. Suppression of MOPC-167 growth in vivo by immunization against the idiotype of the MOPC-167 myeloma protein. Microbiol Immunol. 1979;23(9):927–931. doi: 10.1111/j.1348-0421.1979.tb02827.x. [DOI] [PubMed] [Google Scholar]
  29. Stankus R. P., Leslie G. A. Affinity-immunoadsorbent fractionation of rat anti-streptococcal A carbohydrate antibodies of restricted heterogeneity. J Immunol Methods. 1976;10(4):307–316. doi: 10.1016/0022-1759(76)90025-9. [DOI] [PubMed] [Google Scholar]
  30. Stankus R. P., Leslie G. A. Cross-idiotypic specificity of rat antibodies to group A streptococcal carbohydrate. J Immunol. 1974 Dec;113(6):1859–1863. [PubMed] [Google Scholar]
  31. Stevenson G. T., Elliott E. V., Stevenson F. K. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc. 1977 Aug;36(9):2268–2271. [PubMed] [Google Scholar]
  32. Strayer D. S., Lee W. M., Rowley D. A., Köhler H. Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice. J Immunol. 1975 Feb;114(2 Pt 2):728–733. [PubMed] [Google Scholar]
  33. Sy M. S., Dietz M. H., Germain R. N., Benacerraf B., Greene M. I. Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors. J Exp Med. 1980 May 1;151(5):1183–1195. doi: 10.1084/jem.151.5.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Trenkner E., Riblet R. Induction of antiphosphorylcholine antibody formation by anti-idiotypic antibodies. J Exp Med. 1975 Nov 1;142(5):1121–1132. doi: 10.1084/jem.142.5.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Vandenbark A. A., Greene M. H., Burger D. R., Vetto R. M., Reimer R. R. Immune response to melanoma extracts in three melanoma-prone families. J Natl Cancer Inst. 1979 Nov;63(5):1147–1151. [PubMed] [Google Scholar]
  36. Vincent A. Idiotype restriction in myasthenia gravis antibodies. Nature. 1981 Mar 26;290(5804):293–294. doi: 10.1038/290293a0. [DOI] [PubMed] [Google Scholar]
  37. Yamamoto H., Nonaka M., Katz D. H. Suppression of hapten-specific delayed-type hypersensitivity responses in mice by idiotype-specific suppressor T cells after administration of anti-idiotypic antibodies. J Exp Med. 1979 Oct 1;150(4):818–829. doi: 10.1084/jem.150.4.818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zanetti M., Bigazzi P. E. Anti-idiotypic immunity and autoimmunity. I. In vitro and in vivo effects of anti-idiotypic antibodies to spontaneously occurring autoantibodies to rat thyroglobulin. Eur J Immunol. 1981 Mar;11(3):187–195. doi: 10.1002/eji.1830110306. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES